文献速递肝病消化道肿瘤与早癌

肝硬化并发症发生随时间变化的不平等:一项队列研究

Inequalities in Developing Cirrhosis Complications Over Time: A Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2025-02-05

该回顾性队列研究纳入2010年1月10日至2015年8月30日在130家退伍军人事务医疗机构诊断为代偿期肝硬化的成年患者,随访至2023年8月31日。采用7状态15转移的半马尔可夫多状态模型评估向腹水、肝性脑病、静脉曲张出血、肝细胞癌、多种并发症或死亡的进展。中位随访5.3年,49.8%进展为单一并发症,以腹水(30.3%)最常见,3.1%进展为多种并发症,12.9%直接死于非肝相关原因,26%保持代偿。

要点

  • 中位随访5.3年,49.8%的代偿期肝硬化患者进展为单一并发症,腹水(30.3%)最常见。
  • 12.9%直接死于非肝相关原因,26%保持代偿;2年内死亡风险为13.5%,高于任何并发症状态的风险。
  • 年轻患者和酒精相关肝硬化患者进展更快;老年患者和活动性丙型肝炎病毒感染者肝细胞癌发生率更高。

核心结论

  • 在当代肝硬化队列中,半数患者出现进展,部分保持代偿,相当比例直接死亡,年龄和病因显著影响结局。
  • 这些数据凸显在首次并发症发生前的高收益期进行干预的重要性。

研究设计与样本

  • 回顾性队列研究,纳入2010年1月10日至2015年8月30日在130家退伍军人事务医疗机构诊断为代偿期肝硬化的成年患者,随访至2023年8月31日。
  • 采用7状态、15转移的半马尔可夫多状态模型,将年龄和病因(治愈/活动性丙型肝炎病毒、酒精、代谢功能障碍相关脂肪性肝病)作为时变因素。

主要发现

  • 共识别24,679例代偿期肝硬化患者,中位随访5.3年。
  • 49.8%进展为单一并发症,腹水(30.3%)最常见,3.1%进展为多种并发症。
  • 12.9%直接死于非肝相关原因,26%保持代偿。
  • 2年内向死亡转移的风险为13.5%,高于任何并发症状态的风险。
  • 年轻患者和酒精相关肝硬化患者进展更快;老年患者和活动性丙型肝炎病毒感染者肝细胞癌发生率更高;酒精与代谢功能障碍相关脂肪性肝病患者的转移率相似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Current knowledge of cirrhosis progression is derived from outdated data. We examined the progression patterns of cirrhosis in a contemporary cohort. METHODS: We conducted a retrospective cohort study of adult patients diagnosed with compensated cirrhosis at 130 Veterans Affairs healthcare facilities from January 10, 2010, to August 30, 2015, with follow-up through August 31, 2023. A semi-Markov multistate model with 7 states and 15 transitions was used to evaluate the progression from compensated cirrhosis to ascites, hepatic encephalopathy, variceal bleeding, hepatocellular carcinoma, multiple complications, or death, considering age and etiology (cured/active hepatitis C virus, alcohol, metabolic dysfunction-associated steatotic liver disease) as time-varying factors. RESULTS: We identified 24,679 patients with compensated cirrhosis. Over a median follow-up of 5.3 years, 49.8% progressed to a single complication, with ascites (30.3%) being the most common, and 3.1% progressed to multiple complications. A total of 12.9% transitioned directly to death from non-liver-related causes, whereas 26% remained compensated. The 2-year risk of transitioning to death was 13.5%, exceeding the risk of any complication state. Younger patients and those with alcohol-related cirrhosis had faster progression, whereas older patients and those with active hepatitis C virus had a higher incidence of hepatocellular carcinoma. Transition rates were similar for patients with alcohol and metabolic dysfunction-associated steatotic liver disease. DISCUSSION: In a contemporary cirrhosis cohort, half of patients progressed, whereas others remain compensated, and a large fraction transitioned directly to death, with age and etiology significantly influencing outcomes. These data highlight the importance of interventions in the high-yield period before the first complication.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Cholankeril G, Taylor T, Kramer JR, et al. Inequalities in Developing Cirrhosis Complications Over Time: A Cohort Study. Am J Gastroenterol. 2025. PMID: 39907257. doi:10.14309/ajg.0000000000003354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。